OverviewSuggest Edit
3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
| Type | Public | |
| Founded | 1993 | |
| HQ | George Town, KY | Map |
| Website | 3sbio.com |
Locations
3sbio Office Locations
3sbio has an office in George Town
George Town, KY (HQ)
SIX 2nd Floor Cricket Square, 171 Elgin Ave
3sbio Financials and Metrics
3sbio Revenue
3sbio's revenue was reported to be ¥5.59 b in FY, 2020
| CNY | |
|---|---|
Revenue (H1, 2021) | 3.1b |
Gross profit (H1, 2021) | 2.8b |
Net income (H1, 2021) | 891.0m |
EBITDA (H1, 2021) | 1.1b |
EBIT (H1, 2021) | 946.0m |
Market capitalization (19-May-2022) | 14.5b |
Closing stock price (19-May-2022) | 5.6 |
Cash (30-Jun-2021) | 2.9b |
EV | 14.3b |
3sbio's current market capitalization is $14.5 b.
Annual
| CNY | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Revenue | 4.6b | 5.3b | 5.6b |
Cost of goods sold | (564.0m) | (591.4m) | (702.0m) |
Gross profit | 4.1b | 4.8b | 5.0b |
R&D expense | (362.7m) | (526.6m) | (590.3m) |
Half Year
| CNY | H1, 2019 | H1, 2020 | H1, 2021 |
|---|---|---|---|
Revenue | 2.6b | 2.7b | 3.1b |
Cost of goods sold | (292.6m) | (303.6m) | (360.3m) |
Gross profit | 2.4b | 2.4b | 2.8b |
R&D expense | (263.9m) | (254.3m) | (344.9m) |
Annual
| CNY | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Cash | 1.8b | 2.1b | 3.1b |
Accounts Receivable | 1.3b | 930.8m | 860.0m |
Prepaid Expenses | 45.1m | 49.1m | 112.7m |
Inventories | 384.6m | 528.5m | 619.5m |
Half Year
| CNY | H1, 2019 | H1, 2020 | H1, 2021 |
|---|---|---|---|
Cash | 1.4b | 3.8b | 2.9b |
Accounts Receivable | 1.5b | 1.1b | 1.2b |
Prepaid Expenses | 756.4m | 504.8m | 582.7m |
Inventories | 449.8m | 569.9m | 681.5m |
Annual
| CNY | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
Net Income | 1.5b | 1.2b | 979.1m |
Depreciation and Amortization | 313.3m | 320.7m | 342.1m |
Inventories | (35.7m) | (124.9m) | (93.1m) |
Accounts Payable | (51.8m) | 37.0m | 53.2m |
Half Year
| CNY | H1, 2019 | H1, 2020 | H1, 2021 |
|---|---|---|---|
Net Income | 406.6m | 818.6m | 1.0b |
Depreciation and Amortization | 164.1m | 167.0m | 149.0m |
Inventories | (66.1m) | (37.3m) | (57.1m) |
Accounts Payable | 57.4m | 16.4m | 11.7m |
3sbio Revenue Breakdown
3sbio revenue breakdown by business segment: 100.0% from PHARMACEUTICAL DIVERSIFIED
3sbio Cybersecurity Score
3sbio Environment, Social & Governance (ESG) Ratings
3sbio Online and Social Media Presence
3sbio's Trends
3sbio Frequently Asked Questions
When was 3sbio founded?
3sbio was founded in 1993.
How many employees does 3sbio have?
3sbio has 5,232 employees.
What is 3sbio revenue?
Latest 3sbio annual revenue is ¥5.6 b.
What is 3sbio revenue per employee?
Latest 3sbio revenue per employee is ¥1.1 m.
Who are 3sbio competitors?
Competitors of 3sbio include BioNTech, Jiangsu Hansoh Pharmaceutical Group and Takeda Oncology.
Where is 3sbio headquarters?
3sbio headquarters is located at SIX 2nd Floor Cricket Square, 171 Elgin Ave, George Town.
Where are 3sbio offices?
3sbio has an office in George Town.
How many offices does 3sbio have?
3sbio has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies